IL-18 additionally stimulates interleukin-6 (IL-6) and Granulocyte–macrophage colony-stimulating factor (GM-CSF) [9], blockade of which have yielded therapeutics for severe COVID-19 [10, 11]. The gene discussed is IL6; the disease is COVID-19.